HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

K Ishikawa Selected Research

P-Type Calcium Channels (P-Type Calcium Channel)

4/2000Spinocerebellar ataxia type 6 mutation alters P-type calcium channel function.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


K Ishikawa Research Topics

Disease

19Neoplasms (Cancer)
11/2013 - 01/2000
13Myocardial Infarction
10/2011 - 01/2000
12Ischemia
01/2005 - 04/2000
11Neoplasm Metastasis (Metastasis)
11/2009 - 01/2000
8Hypertension (High Blood Pressure)
09/2004 - 01/2000
7Essential Hypertension
09/2004 - 02/2000
7Myocardial Ischemia (Ischemic Heart Diseases)
12/2001 - 04/2000
7Cardiovascular Diseases (Cardiovascular Disease)
09/2001 - 01/2000
6Stomach Neoplasms (Stomach Cancer)
01/2009 - 02/2000
4Inflammation (Inflammations)
01/2016 - 05/2001
4Insulin Resistance
03/2015 - 12/2001
4Colorectal Neoplasms (Colorectal Cancer)
01/2009 - 11/2000
4Brain Ischemia (Cerebral Ischemia)
12/2001 - 05/2000
4Coronary Stenosis (Coronary Artery Stenosis)
12/2001 - 05/2000
4Atherosclerosis
10/2001 - 02/2000
4Spinocerebellar Ataxias (Spinocerebellar Ataxia)
06/2001 - 01/2000
3Infections
01/2017 - 11/2001
3Liver Diseases (Liver Disease)
10/2008 - 01/2001
3Lymphatic Metastasis
06/2008 - 11/2000
3Pneumoperitoneum
08/2005 - 06/2000
3Infarction (Infarctions)
06/2001 - 04/2000
2Stroke (Strokes)
01/2020 - 12/2001
2Breast Neoplasms (Breast Cancer)
01/2017 - 06/2006
2Diabetic Retinopathy (Retinopathy, Diabetic)
01/2016 - 01/2009
2Fibrosis (Cirrhosis)
02/2015 - 01/2009
2Hypoxia (Hypoxemia)
11/2013 - 11/2000
2Obesity
12/2010 - 12/2001
2Dehydration (Water Stress)
07/2010 - 11/2008
2Lymphoma (Lymphomas)
06/2010 - 07/2002
2Esophageal Squamous Cell Carcinoma
01/2009 - 04/2008
2Machado-Joseph Disease (Spinocerebellar Ataxia Type 3)
12/2007 - 10/2000
2Carcinoma (Carcinomatosis)
03/2006 - 11/2000
2Glucose Intolerance
10/2004 - 12/2001
2Rectal Neoplasms (Rectal Cancer)
09/2004 - 11/2001
2Adenocarcinoma
09/2004 - 11/2001
2Liver Cirrhosis (Hepatic Cirrhosis)
07/2004 - 03/2000
2Nonaka type Distal myopathy
05/2004 - 08/2002
2Asthma (Bronchial Asthma)
06/2003 - 08/2001
2Hyperplasia
12/2001 - 02/2001
2Ventricular Tachycardia
08/2001 - 01/2001
2Rheumatoid Arthritis
08/2001 - 03/2000

Drug/Important Bio-Agent (IBA)

6Proteins (Proteins, Gene)FDA Link
11/2013 - 01/2000
6Messenger RNA (mRNA)IBA
01/2009 - 08/2000
6Phosphorus (Red Phosphorus)IBA
09/2001 - 04/2000
5Glutamic Acid (Glutamate)FDA Link
12/2001 - 05/2000
5Adenosine Triphosphate (ATP)IBA
09/2001 - 04/2000
4Pharmaceutical PreparationsIBA
01/2017 - 06/2000
4EnzymesIBA
01/2016 - 04/2000
4Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
07/2001 - 04/2000
3Phosphotransferases (Kinase)IBA
01/2017 - 08/2001
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2006 - 10/2004
3Indicators and Reagents (Reagents)IBA
03/2006 - 05/2000
3DobutamineFDA LinkGeneric
12/2001 - 03/2001
3Angiotensin IIIBA
07/2001 - 04/2000
3candesartanIBA
07/2001 - 04/2000
3Angiotensin II Type 1 Receptor BlockersIBA
07/2001 - 04/2000
3DNA (Deoxyribonucleic Acid)IBA
02/2001 - 03/2000
3NitratesIBA
12/2000 - 01/2000
3Oxygen (Dioxygen)IBA
11/2000 - 05/2000
3Calcium Channels (Calcium Channel)IBA
10/2000 - 01/2000
3CholesterolIBA
06/2000 - 02/2000
3Radioisotopes (Radionuclides)IBA
06/2000 - 04/2000
2C-Reactive ProteinIBA
01/2020 - 12/2001
2ImmunosorbentsIBA
01/2016 - 10/2008
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2016 - 02/2015
2Doxorubicin (Adriamycin)FDA LinkGeneric
09/2014 - 05/2000
2Anesthetics (Anesthetic Agents)IBA
01/2014 - 01/2001
2matrigelIBA
11/2013 - 06/2002
2Sucrose (Saccharose)IBA
07/2010 - 11/2008
2SolutionsIBA
07/2010 - 11/2008
2Carbon DioxideIBA
08/2005 - 04/2005
2SodiumIBA
09/2004 - 02/2000
2AcetylglucosamineIBA
05/2004 - 08/2002
2Uridine Diphosphate (UDP)IBA
05/2004 - 08/2002
2N-acylmannosamine kinaseIBA
05/2004 - 08/2002
2Racemases and Epimerases (Epimerases and Racemases)IBA
05/2004 - 08/2002
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
12/2001 - 05/2000
2Dipyridamole (Persantine)FDA LinkGeneric
12/2001 - 08/2001
2Tissue Plasminogen Activator (Alteplase)FDA Link
12/2001 - 02/2001
2ThrombinFDA Link
12/2001 - 01/2000
2Nitric Oxide (Nitrogen Monoxide)FDA Link
09/2001 - 03/2001
2Glyburide (Glibenclamide)FDA LinkGeneric
09/2001 - 05/2001
2Nitric Oxide Synthase (NO Synthase)IBA
09/2001 - 07/2001
2NG-Nitroarginine Methyl Ester (L-NAME)IBA
09/2001 - 07/2001

Therapy/Procedure

9Therapeutics
02/2015 - 01/2000
7Drug Therapy (Chemotherapy)
09/2014 - 02/2000
4Transplantation
10/2006 - 11/2001
3Bone Marrow Transplantation (Transplantation, Bone Marrow)
09/2006 - 06/2001
3Radiotherapy
09/2004 - 11/2000
3Electrodes (Electrode)
12/2001 - 11/2000
3Palliative Care (Palliative Therapy)
04/2001 - 01/2000
2Aftercare (After-Treatment)
02/2021 - 11/2001
2Vitrectomy
01/2016 - 01/2009
2Gastrectomy
03/2006 - 08/2004
2Lymph Node Excision (Lymph Node Dissection)
03/2006 - 06/2001
2Anesthesia
08/2005 - 04/2005
2Laparotomy
08/2005 - 04/2005
2Kidney Transplantation
01/2005 - 11/2001
2Intravenous Infusions
12/2001 - 03/2001
2Catheters
12/2001 - 06/2001